Search

everythinglearnresearchcommunity

for

Search:↓

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Androgen use may increase the risk of stroke, but more research is needed.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Australia needs better dermatological guidelines for gender-diverse patients.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Engineering strategies improve stem cells' ability to heal wounds effectively.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

New methods may speed up drug development for male subfertility.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

PCOS requires personalized treatment to improve life quality and reduce health risks.